| Ischemic stroke: emergencies and management. | |
| | |
MedLine Citation:
|
PMID: 22284060 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The past 40 years have seen the evolution of acute ischemic stroke management from unproven therapies du jour, such as steroids, heparin for stroke in evolution, and hypervolemic-hemodilution, to more of a scientific basis for our decision-making process. This evolution is directly related to the advancements in imaging of stroke. It is also related to carefully designed, controlled clinical trials of potential therapies, which have led to the recognition of the benefits of thrombolytic therapy in the acute setting but have also caused confusion and frustration over the lack of benefit for potential neuroprotective agents that once seemed promising. |
| | |
Authors:
|
Roger E Kelley; Sheryl Martin-Schild |
Publication Detail:
|
Type: Journal Article Date: 2011-10-20 |
Journal Detail:
|
Title: Neurologic clinics Volume: 30 ISSN: 1557-9875 ISO Abbreviation: Neurol Clin Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8219232 Medline TA: Neurol Clin Country: United States |
Other Details:
|
Languages: eng Pagination: 187-210 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Neurology, Tulane University School of Medicine, 1430 Tulane Avenue 8065, New Orleans, LA 70112, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neuromuscular disorders and acute respiratory failure: diagnosis and management.
Next Document: Intracranial hemorrhage: diagnosis and management.